In Loss For Merck, Amneal Gets OK For Generic Nasal Spray
A generic nasal spray developed by Amneal Pharmaceuticals LLC does not infringe a Merck & Co. Inc. patent covering an active ingredient in Merck's Nasonex, a Delaware federal judge ruled Monday...To view the full article, register now.
Already a subscriber? Click here to view full article